Medicine’s Wild West: 10 new genetic tests enter the market each day
By Carolyn Y. Johnson,
The Washington Post
| 05. 07. 2018
There are 75,000 genetic tests available for sale today -- a flood of information that could provide major new insights into health or an unwieldy abundance of information that overloads doctors and drives medical spending higher.
A new study in the journal Health Affairs reveals an explosion of genetic tests over the past four years, with about 10 new ones entering the market each day. Another study, of hundreds of primary-care providers in New York City, found only a third had ever ordered a genetic test or referred a patient for counseling. A minority -- 14 percent -- said they felt confident interpreting results.
The studies point to the huge opportunity and challenges that face the booming business of clinical genomics, which is forecast to grow to a $7.7 billion global industry by 2020. As the cost of sequencing genes has plummeted and tests have proliferated, the knowledge about the best practical uses of such information in the real world has remained relatively nascent. Doctors want better tools to support their decisions.
“If I were a provider trying to figure out what to order, that's...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
